Foundation for Innovative New Diagn

$5,000,000.00 CAD

≈ le salaire annuel moyen de 65 Canadiens
Ministère
Global Affairs Canada
Programme
Pays bénéficiaire
Canada
Exercice financier
2022-2023
Période de l'entente
27 janvier 2023 – 31 mars 2025
Référence
CA-3-P009757003

Objet publié

This project builds on Canada’s funding to the Foundation for Innovative New Diagnostics (FIND) during COVID-19. The initial project aims at accelerate the roll-out of safe, affordable, and effective COVID-19 diagnostics in Low- and Lower-Middle Income Countries. This project supports FIND in using testing technologies developed during COVID-19 to expand the range of diseases detected with a single test. This includes other respiratory diseases, sexually transmitted infections, and Human papillomavirus (HPV)-based screening for cervical cancer. The project aims to increase testing for the most marginalized, including women, children, and vulnerable groups. Project activities include: (1) supporting the development of more straightforward sample collection methods, including self-sampling; and (2) conducting in-country customer preference surveys and barrier-to-access surveys to guide the final development and introduction of tests.

Étiquettes communautaires

Les étiquettes sont appliquées par les lecteurs, pas par ce site. Une étiquette par personne par enregistrement.

Good value Local impact Needs context Questionable Success story Wasteful
Voir l'enregistrement source officiel Importé le 30 juillet 2026 depuis Données IITA d'Affaires mondiales Canada